Age was the only factor at baseline associated with mortality risk in acromegaly (HR 1.16 (95% CI 1.07–1.26)), whereas sex, IGF-1/ULN levels, tumor size at diagnosis, and first treatment modality (surgery or SSAs) did not influence mortality risk (Table 2). The gene discussed is IGF1; the disease is neoplasm.